JV with Moosehead Breweries Readying Cannabis-Infused Beverages for Commercialization
Source: Streetwise Reports  (10/8/19)
Progress has been made in all areas, from testing the product to evaluating distributors. More >

Healthcare Tech Company Switches to EY Blockchain Platform
Source: Streetwise Reports  (10/7/19)
This will help its customers access the products and tools they need more sustainably. More >

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer for Investigative Antisense Therapy, Shares Up 30%
Source: Streetwise Reports  (10/7/19)
Akcea Therapeutics' shares are trading 30% higher today on news that it has entered into a worldwide exclusive licensing agreement with Pfizer for AKCEA-ANGPTL3-LRx used in the treatment of patients with cardiovascular and metabolic diseases. More >

Healthcare Tech Firm Expands Patient Base in Texas
Source: Streetwise Reports  (10/4/19)
The company landed five new U.S. facilities as customers. More >

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial
Source: Streetwise Reports  (10/3/19)
This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection. More >

Zynex Shares Trade Higher After Reporting a 95% Increase in Q3 Orders
Source: Streetwise Reports  (10/2/19)
Non-invasive medical device maker Zynex Inc's. shares are trading 12% higher on an overall down market day after the company reported that Q3/19 orders are up 95% over the same period in 2018. More >

Phase 2 Data from Potential Multibagger Biopharma 'Checks All the Boxes'
Source: Streetwise Reports  (9/30/19)
The latest clinical trial results are dissected in a ROTH Capital Partners report. More >

U.S. Biotech Rolls Out New Brachytherapy Delivery Tool Used for Prostate Cancer
Source: Streetwise Reports  (9/30/19)
The system, target markets and the marketing campaign for it are discussed in a Dawson James Securities report. More >

Dova Pharma Shares Rise 38% on Swedish Firm Takeover Offer
Source: Streetwise Reports  (9/30/19)
Shares of Dova Pharmaceuticals opened 38% higher today on news that the firm will be acquired by Swedish Orphan Biovitrum. The deal is reportedly valued at $915 million or $29/share. More >

Aravive Shares Rise on Positive Patient Data from Phase 1b Ovarian Cancer Study
Source: Streetwise Reports  (9/27/19)
Shares of Aravive Inc. are trading higher after the firm posted positive data from the initial 12 patients enrolled in the Phase 1b portion of its study of AVB-500 used in the treatment of ovarian cancer. More >

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results
Source: Streetwise Reports  (9/26/19)
Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. More >

Shares Rise as The Medicines Company Reports Positive Topline Results from Two Phase 3 Cholesterol Trials
Source: Streetwise Reports  (9/25/19)
The Medicines Company's shares are trading 8.5% higher today after the firm reported positive results from two phase 3 studies for inclisiran, one for familial hypercholesterolemia, which leads to high levels of LDL-C, and one for atherosclerotic cardiovascular disease. More >

PhaseBio Shares Are on a Tear After Reporting Phase 2a Trial Results
Source: Streetwise Reports  (9/25/19)
The clinical-stage biopharmaceutical stock surged more than 30% Wednesday following a report that PB2452 caused immediate and sustained reversal of ticagrelor in older and elderly subjects. More >

Analyst: Acquisition by Colorado-Based Specialty Pharma 'Could Bolster Revenue 400%'
Source: Streetwise Reports  (9/24/19)
The benefits and terms of the agreement are outlined in a Ladenburg Thalmann report. More >

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial
Source: Streetwise Reports  (9/24/19)
Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. More >

Avadel Pharma Shares Up 30% Upon Acceleration of Phase 3 REST-ON Study
Source: Streetwise Reports  (9/23/19)
Avadel Pharmaceuticals' shares are trading 30% higher today on news that the FDA agreed to reduce the sample size required for its Phase 3 REST-ON study, accelerating its completion by year-end 2019. More >

Cannabis Company Expands Operations with New Plant
Source: Streetwise Reports  (9/20/19)
The firm will use this second manufacturing facility only for making reagents. More >

Mobile Health, Telemedicine Solutions Firm Lands Five New Clients
Source: Streetwise Reports  (9/20/19)
With these new contracts, the Vancouver-based company continues to build its momentum in Texas. More >

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation
Source: Streetwise Reports  (9/20/19)
Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Products for Human Use also adopted a positive opinion for Dupixent in a third indication. More >

Biopharma Reports Positive Data from Alcoholic Hepatitis Study
Source: Streetwise Reports  (9/18/19)
These results are from the recently completed clinical trial of the firm's lead drug candidate. More >

NCI Chooses Veterinary Biopharma as Select Manufacturing Contractor
Source: Streetwise Reports  (9/18/19)
The contract's meaning, terms and benefits and the California firm's near-term catalysts are discussed in an H.C. Wainwright & Co. report. More >

Alder BioPharmaceuticals Shares Surge 80% on Acquisition News
Source: Streetwise Reports  (9/16/19)
Shares of migraine treatment research firm Alder BioPharmaceuticals opened 84% higher today after the company announced that it has agreed to be acquired by H. Lundbeck for $1.95 billion. More >

Healthcare Company Rolls Out Patient App Access to Electronic Medical Records System
Source: Streetwise Reports  (9/13/19)
This is one way the Canadian firm is providing convenient, patient-centric service. More >

Fibrocell Science Shares Rise 60% on Acquisition News
Source: Streetwise Reports  (9/13/19)
Fibrocell Science's shares are trading up 60% today after the company announced that it agreed to be acquired by Castle Creek Holdings for $63.3 million, or $3.00 per share. More >

Moderna Shares Rise on the Release of Positive Results from Two mRNA Phase 1 Programs
Source: Streetwise Reports  (9/12/19)
Shares of Moderna Inc. traded up double-digits as the firm announced results from its Phase 1 CMV Vaccine Study as well as its Phase 1 data for mRNA-1944 encoding for antibody against the chikungunya virus. More >